Search research articles
Contact Us
Filters
Showing results (561-570 of 724) with videos related to
Page
of 73
Sort By:
The Journal of Dermatological Treatment
|
April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials
S Barbarot, A Wollenberg, J I Silverberg, et al.
Acta Dermato-Venereologica
|
May 27, 2021
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
Mette Deleuran, Danielle Marcoux, Marjolein S Bruin-Weller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 4, 2025
Dupilumab improves quality of life assessed by the Quality of Life in Hand Eczema Questionnaire
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
Dermatology and Therapy
|
July 11, 2025
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
Dermatology and Therapy
|
December 29, 2025
A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'"
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
European Journal of Medicinal Chemistry
|
October 3, 2006
High selective leishmanicidal activity of 3-hydroxy-2-methylene-3-(4-bromophenyl)propanenitrile and analogous compounds
R O M A de Souza, V L P Pereira, M F Muzitano, et al.
The British Journal of Dermatology
|
March 20, 2014
Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial
T Passeron, A Maza, E Fontas, et al.
Annals of Nuclear Medicine
|
June 3, 2016
(18)F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes
Dalton A Dos Anjos, Angelita Habr-Gama, Bruna B Vailati, et al.
Acta Dermato-Venereologica
|
October 7, 2021
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
Jonathan I Silverberg, Eric L Simpson, Mark Boguniewicz, et al.
The British Journal of Dermatology
|
February 6, 2019
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials
A Blauvelt, D Rosmarin, T Bieber, et al.
Page
of 73
Search research articles
Search
Showing results (561-570 of 724) with videos related to
Sort By:
Page
of 73
The Journal of Dermatological Treatment
|
April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials
S Barbarot, A Wollenberg, J I Silverberg, et al.
Acta Dermato-Venereologica
|
May 27, 2021
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
Mette Deleuran, Danielle Marcoux, Marjolein S Bruin-Weller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 4, 2025
Dupilumab improves quality of life assessed by the Quality of Life in Hand Eczema Questionnaire
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
Dermatology and Therapy
|
July 11, 2025
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
Dermatology and Therapy
|
December 29, 2025
A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'"
Sonja Ständer, Andreas Pinter, Firas G Hougeir, et al.
European Journal of Medicinal Chemistry
|
October 3, 2006
High selective leishmanicidal activity of 3-hydroxy-2-methylene-3-(4-bromophenyl)propanenitrile and analogous compounds
R O M A de Souza, V L P Pereira, M F Muzitano, et al.
The British Journal of Dermatology
|
March 20, 2014
Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial
T Passeron, A Maza, E Fontas, et al.
Annals of Nuclear Medicine
|
June 3, 2016
(18)F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes
Dalton A Dos Anjos, Angelita Habr-Gama, Bruna B Vailati, et al.
Acta Dermato-Venereologica
|
October 7, 2021
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
Jonathan I Silverberg, Eric L Simpson, Mark Boguniewicz, et al.
The British Journal of Dermatology
|
February 6, 2019
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials
A Blauvelt, D Rosmarin, T Bieber, et al.
Page
of 73